baber/WOPTO huggingface dataset:
Patent FI-950125-A0 (FI)
Inventor: BRANDHORST GERD
IPC: B65D83/76
Filed: 1995-01-11
Abstract: The device has a ring arranged on the open end of the tubular container (15). A cylindrical housing (1) is provided which encloses the container and has a cap (2) that has an outlet opening (9) and which surrounds and cooperates with the ring to seal the open end of the container. The housing has a piston (3) which slides within it to compress the container as desired.  The ring (17) has an edge part (19) exceeding the size of the housing's (1) internal diameter for placing on a housing-support surface (5) facing the cap (2). One end part (4) of the housing, and a cylindrical end part (7) of the cap interlock, so that the ring's edge part leads from the inner wall of the outer one of the two end parts (4,7). The interlocking end parts of the housing and the cap leave a clearance between their facing surfaces (6,8). The ring has a conical sealing surface (20).
Patent FI-950532-A0 (FI)
Inventor: KUIJK EGBERT WILLEM
IPC: C09D123/06
Filed: 1995-02-07
Abstract: The invention relates to the use of low-density polyethylene (LDPE) for extrusion coating involving the addition of 50-1000 ppm vitamin E to the LDPE. This addition causes the organoleptic properties of the extrusion-coated LDPE to improve without causing the adhesion to the substrate to deteriorate, even at very high processing temperatures as commonly used for extrusion coating, at which large amounts of oxidative degradation products are formed, only a very small amount of vitamin E suffices.
Patent FI-962234-A0 (FI)
Inventor: WOODINGS CALVIN ROGER
IPC: D21H13/08
Filed: 1996-05-28
Abstract: PCT No. PCT/GB94/02581 Sec. 371 Date May 28, 1996 Sec. 102(e) Date May 28, 1996 PCT Filed Nov. 24, 1994 PCT Pub. No. WO95/14398 PCT Pub. Date Jun. 1, 1995A cigarette filter in which the body of the filter comprises paper containing, or consisting essentially of, lyocell fibres. The invention also relates to a cigarette incorporsting such a filter.
Patent FI-971986-A0 (FI)
Inventor: MUELLER RAINER H
IPC: C09K23/56
Filed: 1997-05-09
Abstract: PCT No. PCT/EP95/04401 Sec. 371 Date Jun. 19, 1997 Sec. 102(e) Date Jun. 19, 1997 PCT Filed Nov. 9, 1995 PCT Pub. No. WO96/14830 PCT Pub. Date May 23, 1996Provided is a drug carrier comprising particles of at least one pure active compound which is insoluble, only sparingly soluble or moderately soluble in water, aqueous media and/or organic solvents, wherein said active ingredient is solid at room temperature and has an average diameter, determined by photon correlation spectroscopy (PCS) of 10 nm to 1,000 nm, the proportion of particles larger than 5  mu m in the total population being less than 0.1% (number distribution determined with a Coulter counter), and, when introduced into water, aqueous media and/or organic solvents, the active compound has an increased saturation solubility and an increased rate of dissolution compared with powders of the active compound prepared using an ultrasonic probe, a ball mill or a pearl mill, the solid particles having been comminuted, without prior conversion into a melt, by using cavitation or shearing and impact forces with introduction of a high amount of energy.
Patent AP-9801171-A0 (AP)
Title: Method for conveying data between a plurality of geographically-remote sender and recipient sites.
Inventor: DRISCOLL EDWARD J III
IPC: H04L12/58
Filed: 1997-04-11
Abstract: The method for electronically conveying large blocks of data between geographically-remote locations by uploading the sender's data to the local hub site of a service provider's network, earmarking that data with an electronic invoice, transmitting that data via the service provider's high speed network to a secondary hub site that is local to the recipient's geograhic location, and downloading the data from the second hubsite to the recipient's network. Duplicate archival versions of the transmitted data may be maintained at two geographically-distinct locations, such as the service provider's primary and secondary network hub sites. The total number of network connections may be reduced with a minimum number of alternative connections maintained to ensure data delivery in the event of a network connection failure. Value-added services may be performed on the data either prior or subsequent to its transmission between the primary and secondary hub sites
Patent IL-60532-A0 (IL)
Title: 2-alkoxyphenyl-imidazo(4,5-b)pyridines,their preparation and pharmaceutical compositions containing them
IPC: A61P9/12
Filed: 1980-07-09
Abstract: Compounds of the formula   <IMAGE>   wherein R1 is alkoxy of 1 to 3 carbon atoms; and R2 is (aralkylsulfinyl of 7 to 9 carbon atoms)-(alkoxy of 2 to 3 carbon atoms); or (unsubstituted, mono-, di- or trisubstituted phenyl-sulfinyl)-(alkoxy of 2 to 3 carbon atoms), where the substituents are attached to the phenyl moiety and are nitro, alkyl of 1 to 3 carbon atoms, alkoxy of 1 to 3 carbon atoms or halogen; their 3H-tautomers; and non-toxic, pharmacologically acceptable acid addition salts thereof. The compounds are useful as hypertensives and cardiotonics.
Patent IL-71757-A0 (IL)
Title: Chamber for the treatment of cells in an electrical field
IPC: C12N15/02
Filed: 1984-05-04
Abstract: A chamber for the treatment of cells in an electrical field, in which a space is provided to hold the suspension containing the cells and into which extend at least two electrodes. The cells are exposed to an electrical field developed between the electrodes. The chamber is also provided with an accessory vessel removably connected thereto for further treatment of the cells.
Patent IL-84194-A0 (IL)
Title: Oil-soluble metal salts of alkyl phosphoric acid esters and compositions containing said salts
IPC: C10N10/04
Filed: 1987-10-18
Abstract: A method of preparing metal salts of substituted phosphoric acid compositions. Such metal salt compositions are useful in lubricating oils, fuels, functional fluids, aqueous systems and have utility as a high torque extreme pressure agent.
Patent IL-85660-A0 (IL)
Title: Dehydrating kiln
IPC: C04B11/028
Filed: 1988-03-07
Abstract: PCT No. PCT/FR88/00111 Sec. 371 Date Jan. 6, 1989 Sec. 102(e) Date Jan. 6, 1989 PCT Filed Feb. 29, 1988 PCT Pub. No. WO88/07163 PCT Pub. Date Sep. 22, 1988.Oven for dehydrating pulverulents, sand or granules, comprising an energy-saving dehydration device, adapted to gypsum burning. The device consists of an outer casing, an inner casing and flow cones disposed on said casings. A burner and a lock complete the device. Pressure within the oven is increased by the provision of a cover, a gypsum lock and a steam valve. The process takes place in dry or moist conditions, the latter being advantageous for the processing of insulating products or for gypsum amending the nature of plaster. Heat exchange enables the products to be processed at low temperatures. The central combustion chamber prevents loss by radiation. Application to gypsum burning, during which the device has demonstrated energy savings of 50% in comparison with traditional appliances.
Patent IL-85770-A0 (IL)
Title: Load accumulation system
IPC: B65G1/04
Filed: 1988-03-17
Abstract: An accumulation and storage system, preferably for palletized loads, utilizes a SAILRAIL (trade mark) air support system for guiding and supporting an elongated deck (30) during reciprocal movement thereof. Alongside each edge of the deck is a pallet lifting/lowering mechanism (36) which uses an elongated inflatable tube (42), such as a fire hose, top raise or lower an inverted U-shaped lifting member (40). When the lifting members are raised a pallet can be placed thereon and the deck can reciprocate therebelow. When the lifting members are lowered the pallet rests on the deck and can be moved along the system to a subsequent position where it is raised clear of the deck so that the deck can return to pick up another pallet at the input station. Logic controls can be used to operate the system quickly, efficiently and automatically.
Patent IL-89794-A0 (IL)
Title: Cytotoxic compositions and methods for the preparation thereof
IPC: A61P37/00
Filed: 1989-03-29
Abstract: Anticancer, antimicrobial and autoimmune disease, and anti-organ rejection therapy using cytotoxic agents is improved using cytokines to prevent, mitigate or reverse adverse radiation-induced or drug-induced toxicity, especially to hematopoietic cells. Cytotoxic agents can include radioisotopes, drugs, toxins and even unconjugated antibodies. A preferred cytokine is IL-1. Higher doses of cytotoxic agents can be administered and tolerated by the patient and dose-limiting marrow toxicity can be prevented, palliated or reversed using adjunct cytokine therapy.
Patent IL-92454-A0 (IL)
Title: Drugs with increased dissolution rate and their preparation
IPC: A61K31/00
Filed: 1989-11-27
Abstract: Supported drugs with an increased dissolution rate, prepared by a process comprising mixing the drug with the support material under dry conditions, co-grinding the mixture in a mill with its grinding chamber saturated with the vapour of one or more solvents able to solubilize the drug or to be adsorbed on the surface of the support material, vacuum-drying the product obtained, and sieving. The drugs obtained in this manner have a reduced heat of fusion, a reduced melting point, an increased dissolution rate and an increased solubilization kinetics.
Patent IL-97289-A0 (IL)
Title: Tetraazaacenaphthylene-3-one derivatives,pharmaceutical compositions containing the same and processes for the preparation thereof
IPC: A61P25/28
Filed: 1991-02-20
Abstract: Compounds of formula <CHEM> wherein R1 is hydrogen, alkyl, carboxamidomethyl, 4-chlorophenyl, benzyl and (4-nitrophenyl)-methyl; R2 and R3 are hydrogen or alkyl, R4 is 3-pyridinyl or <CHEM> where R6 and R7 are hydrogen, halogen, alkyl, alkoxy, N-alkyl-N-acylamino, nitro, and trifluoromethyl and where halogen is selected from chlorine, fluorine, bromine and iodine; R5 is hydrogen or alkyl; and A-B is -C=C-R3- or <CHEM> which are useful antihypertensive and anxiolytic agents. c
Patent AU-PQ420599-A0 (AU)
Title: Method and apparatus for determining cardiac output or total peripheral resistance
IPC: A61B5/02
Filed: 1999-11-24
Abstract: A method and apparatus determines continuously mean cardiac output by measuring the arterial pressure e.g. at a finger and calculating therefrom the mean arterial pressure and the time constant of the arterial system (in diastole). Compliance values are provided from a table. Mean cardiac output is then the product of mean arterial pressure and compliance divided by the time constant. Changes in cardiac output can be used for diagnostic purposes. A pressure cuff or pressure tonometer can be used to measure the arterial pressure with a microcomputer providing the necessary calculations. <IMAGE>
Patent FI-20106360-A0 (FI)
Inventor: YLILAMMI MARKKU
IPC: H01L/
Filed: 2010-12-21
Abstract: The invention relates to an ultrasound sensor(1) and a manufacturing method, the sensor (1) comprising an ultrasound transmitter (102, 103, 104), a cavity (4) arranged in connection with this, which is in resonance mode at the ultrasound frequency used,and the sensor (1) comprises a passive sensor element (3, 3'), the distance of which from the ultrasound transmitter (2) is selected in such a way that the resonance condition is met, located at the opposite end of the cavity (4) to the ultrasound transmitter (102, 103, 104). In accordance with the invention the ultrasound transmitter (102, 103, 04) is a piezo-element.
Patent IL-100623-A0 (IL)
Title: Recombinant iga protease
IPC: C12N9/52
Filed: 1992-01-09
Abstract: The present invention relates to a method for obtaining recombinant IgA protease from inclusion bodies. Also claimed is a recombinant DNA which codes for an IgA protease whose C-terminal helper portion and, preferably, also whose N-terminal signal portion is no longer active.
Patent IL-107548-A0 (IL)
Title: Refrigeration working fluid compositions containing trifluoroethane
IPC: C10M105/38
Filed: 1993-11-09
Abstract: There are disclosed refrigeration working fluid compositions comprising 1,1,1-trifluoroethane refrigerant and either a neopentylglycol ester of 3,5,5-trimethylhexanoic acid or a trimethylolpropane ester of a mixture of 65 wt. % 3,5,5-trimethylhexanoic acid, 22.2 wt. % n-heptanoic acid and 12.8 wt. % methylhexanoic acid. The esters exhibit suitable viscosity ranges and miscibility with the refrigerant over a broad compositional range.
Patent IL-126368-A0 (IL)
Title: Process for producing a percarbonate
IPC: C11D3/39
Filed: 1997-03-27
Abstract: Sodium percarbonate exhibits a tendency to decompose in built compositions and particularly detergent compositions built with zeolites. The tendency can be ameliorated by selecting sodium percarbonate which intrinsically has a mean particle size of from 500 to 1000 microns and not more than 20% by weight of below 350 microns and has a moisture pick-up when measured in a test at 80% relative humidity and 32° C. after 24 hours of not greater than 30 g/1000 g sample. A suitable sodium percarbonate can be made most conveniently by crystallisation from a bulk saturated solution of sodium percarbonate in a crystalliser/classifier that does not employ a conventional chloride salting-out agent.
Patent IL-130041-A0 (IL)
Title: Method for treating renal failure
IPC: A61K31/295
Filed: 1997-11-14
Abstract: Methods of controlling phosphate metabolism and metabolic acidosis in patients suffering from renal failure and associated hyperphosphatemia or patients predisposed to development of a hyperphosphatemic condition are provided. The method in accordance with this invention comprises administering to a patient a ferric-containing compound selected from the group consisting of ferric citrate, ferric acetate, and combinations thereof. Therapeutic benefit can be realized in accordance with such method by administering the compound orally to a patient to contact and bind with ingested phosphate in the patient's digestive tract, and thereby prevent its intestinal absorption.
Patent IL-130333-A0 (IL)
Title: Prevention and treatment of skeletal disorder with EP2 receptor subtype selective prostaglandin E2 agonists
IPC: A61P19/10
Filed: 1997-11-27
Abstract: This invention relates to the use of EP2 receptor subtype selective prostaglandin E2 agonists to augment bone mass including the prevention and treatment of skeletal disorders in mammals, including humans.
Patent IL-134126-A0 (IL)
Title: Methods and apparatus for ink capping ink jet printer nozzles
IPC: C09D11/00
Filed: 1998-07-15
Abstract: A chemical solvent based ink composition for use in impulse ink jet printers, comprising: a colorant; glycol ether; ketone alcohol; at least one resin selected from the group consisting of polyester resins and styrene acrylic resins. <IMAGE>
Patent IL-134926-A0 (IL)
Title: Vacuum plasma processor having coil with added conducting segments to its peripheral part
IPC: H01L21/205
Filed: 1998-09-16
Abstract: A vacuum plasma processor for treating a workpiece with an RF plasma has a plasma excitation coil including a peripheral portion supplying a substantial magnetic flux density to peripheral portions of the plasma. Additional conducting segments spatially adjacent to and electrically connected to a segment of the peripheral portion supply additional magnetic flux having a substantial magnetic flux density to the plasma peripheral portions. The additional conductor segments are in each of four corners of the coil, being connected electrically in parallel or series to coil conductor segments forming the corners. In another embodiment, the coil includes several nested conducting corner segments. In different embodiments, the corner segments are (1) coplanar with the remainder of the coil and (2) closer to the plasma than the remainder of the coil. The coil includes two electrically parallel, spiral like windings, each with an interior terminal connected to one output terminal of a matching network and an output terminal connected via a capacitor to another output terminal of the matching network. The capacitor values and the lengths of the windings relative to the plasma RF excitation wavelength are such that current flowing in the coil has maximum and minimum standing wave values in the peripheral and interior coil portions, respectively. The coil and workpiece peripheries have similar rectangular dimensions and geometries.
Patent IL-140532-A0 (IL)
Title: Selective deposition modeling material
IPC: C08L25/06
Filed: 1999-08-10
Abstract: The present invention relates to a selective deposition modeling material containing a base material, a plasticizing component containing at least 10% by weight of at least one plasticizing agent that is solid at ambient conditions, and at least one tackifying resin that is compatible with the base material and the plasticizing component, wherein the modeling material has a viscosity of less than about 30 centipoise at 130° C. The selective deposition modeling material can alternatively contain about 52% to 98% of a reactive polymeric material that is a mixture of at least one compound containing at least one glycidyl group per molecule, at least one compound having at least one terminal unsaturated group per molecule, at least one compound having at least one vinyl ether group per molecule or mixtures thereof; and a cure agent or activator; and optionally a non-reactive polymeric material or wax material, wherein the modeling material contains a fast set inducing segment content of about 10% to 70% by weight. The present invention further relates to a method for producing a three-dimensional article using said modeling materials.
Patent IL-146890-A0 (IL)
Title: Modified chimeric polypeptides with improved pharmacokinetic properties
IPC: A61P17/00
Filed: 2000-05-23
Abstract: Modified chimeric polypeptides with improved pharmacokinetics are disclosed useful for treating eye disorders, including age-related macular degeneration and diabetic retinopathy.
Patent IL-150085-A0 (IL)
Title: New-p2x7 receptor antagonists for use in the treatment of inflammatory, immune or cardiovascular diseases
IPC: A61K31/541
Filed: 2000-12-12
Abstract: The invention provides piperidine compounds of general formula (I) in which A, B, X, Y, Z, R, R1 and R2 are as defined in the specification, their use as medicaments, compositions containing them and processes for their for their preparation.
Patent IL-150121-A0 (IL)
Title: Antipruritic agents for external use
IPC: A61K47/12
Filed: 2000-12-15
Abstract: External agents for treating pruritus comprises aspirin. ACTIVITY : Antipruritic. In tests a 2 weight% aspirin solution applied to insect bites reduced itching by 85.7 % compared to 60.0 % for a 0.1 weight% dexamethasone composition. MECHANISM OF ACTION : None given.
Patent IL-152578-A0 (IL)
Title: Ortho-substituted anthranilic acid amides and their use as medicaments
IPC: A61P7/02
Filed: 2001-05-08
Abstract: Ortho-substituted anthranilic acid amides and use thereof as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis are described.
Patent IL-153423-A0 (IL)
Title: Fire extinguishing system
IPC: A62C3/00
Filed: 2001-06-22
Abstract: A system (10) for dousing a fire, such as a tunnel, includes a conduit (11) for delivering a fire extinguishing liquid and a trough (12) extending parallel to the conduit (11) for receiving liquid from the conduit (11). A carriage (27) is arranged to move on a track comprising an upper edge (19) of the trough (12) and the carriage (27) carries a pump having a nozzle (25), a video camera (33) and an inlet (26) each of which can be controlled robotically from a remote control station. The inlet (26) is deployed in the trough (12) to draw liquid from the trough (12). The system avoids complicated docking procedures for the pump.
Patent IL-154244-A0 (IL)
Title: Miniaturized wearable oxygen concentrator
IPC: A61M16/10
Filed: 2001-08-02
Abstract: A component gas concentrator includes an air compressor, an air-tight first container containing a molecular sieve bed, the first container in fluid communication with the compressor through a first gas conduit, and an air-tight second container in fluid communication with the first container through a second gas conduit. A gas flow controller such as PLC controls actuation of valves mounted to the gas conduits.
Patent IL-155365-A0 (IL)
Title: Safety device for a breechblock of a firearm
IPC: F41A17/42
Filed: 2003-04-10
Abstract: A safety device for a breechblock of a firearm suitable for limiting accidental sliding of a breechblock (14) following knocks to the firearm, comprises a locking lever (15) of the breechblock (14), pivoted to the structure of the firearm in an axis (11) and an elastic return element (18) of the lever (15), suitable for keeping it in its rest position in conditions of normal use of the firearm, the locking lever (15) being equipped with an engagement element (19) for intervention in a seat (20) of the breechblock (14) and with a centre of gravity (G) which is offset with respect to the axis of rotation (11) of the lever (15), suitable for causing its inertial rotation in a middle plane of line (21). <IMAGE>
Patent IL-161889-A0 (IL)
Title: Method for treating diseases with omega interferon
IPC: A61K45/00
Filed: 2002-11-08
Abstract: A method of treating an immunologic, proliferative, or infectious disease in a warm-blooded animal is disclosed. The method comprises administering to the animal omega interferon (IFN) at a dosage and activity for the disease state treated sufficient to induce a therapeutic response in the animal, which dosage and activity for the disease state treated is higher than would be well-tolerated based on data for non-omega IFN's. The omega IFN is administered alone or In combination with a therapeutically effective amount of at least one adjunctive therapeutic agent. Also disclosed is an article of manufacture useful for treating an immunologic, proliferative, or infectious disease, which article comprises (1) omega IFN in a form suitable for administering a therapeutically effective amount of the omega IFN to the subject in order to induce the desired therapeutic response (2) instructions for administering the omega IFN as desired, that is higher than would be well-tolerated based on data for non-omega IFNs.
Patent IL-164287-A0 (IL)
Title: Methods of treatment using ctla-4 antibodies
IPC: A61K39/39
Filed: 2003-04-11
Abstract: The present invention provides method of treatment using human sequence antibodies against human CTLA-4 linked to a cytotoxic agent. In particular, methods of treating cancer and autoimmune disease are provided.
Patent IL-169370-A0 (IL)
Title: Thienopyrimidinediones and their use in the modulation of autoimmune disease
IPC: A61K31/519
Filed: 2005-06-23
Abstract: The invention relates to thienopyrimidinediones of formula (1): in which R<SUP>1</SUP>, R<SUP>2</SUP>, R<SUP>3</SUP>, Q, and Ar are defined in the specification. The invention also relates to processes for the preparation of the compounds of formula (1), pharmaceutical compositions containing these compounds, and use of these compounds in therapy, in particular in immunosuppression therapy.